The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Leuprolide Acetate-Global Market Insights and Sales Trends 2025
Synopsis
Leuprolide acetate is a synthetic nonapeptide that is a potent gonadotropin-releasing hormone receptor (GnRHR) agonist used for diverse clinical applications, including the treatment of prostate cancer, endometriosis, uterine fibroids, central precocious puberty and in vitro fertilization techniques. Leuprolide acetate is given by injection into a muscle or under the skin.
The global Leuprolide Acetate market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Leuprolide Acetate in various end use industries. The expanding demands from the Prostate Cancer, Precocious, Uterine Fibroid and Others, are propelling Leuprolide Acetate market. Intramuscular, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Subcutaneous segment is estimated at % CAGR for the next seven-year period.
Leuprorelin was approved for medical use in the United States in 1985. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. In the United Kingdom a monthly dose costs the NHS about 75.24 pounds. In the United States the equivalent dose has a wholesale cost of 1,011.93 USD.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Mode of Administration, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Leuprolide Acetate, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Leuprolide Acetate market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Leuprolide Acetate market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Leuprolide Acetate sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Leuprolide Acetate covered in this report include Tolmar Pharmaceuticals, Varian Pharmed, Avenit, Takeda Pharmaceutical, Sun Pharmaceutical Industries, Livzon Pharmaceutical, Beijing Biote Pharmaceutical, Soho-YImIng and AbbVie, etc.
The global Leuprolide Acetate market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Tolmar Pharmaceuticals
Varian Pharmed
Avenit
Takeda Pharmaceutical
Sun Pharmaceutical Industries
Livzon Pharmaceutical
Beijing Biote Pharmaceutical
Soho-YImIng
AbbVie
Sanofi
Astellas Pharma
Abbott
Merck
Pfizer
Global Leuprolide Acetate market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Leuprolide Acetate market, Segment by Mode of Administration:
Intramuscular
Subcutaneous
Global Leuprolide Acetate market, by Application
Prostate Cancer
Precocious
Uterine Fibroid
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Mode of Administration, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Leuprolide Acetate manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Leuprolide Acetate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Leuprolide acetate is a synthetic nonapeptide that is a potent gonadotropin-releasing hormone receptor (GnRHR) agonist used for diverse clinical applications, including the treatment of prostate cancer, endometriosis, uterine fibroids, central precocious puberty and in vitro fertilization techniques. Leuprolide acetate is given by injection into a muscle or under the skin.
The global Leuprolide Acetate market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Leuprolide Acetate in various end use industries. The expanding demands from the Prostate Cancer, Precocious, Uterine Fibroid and Others, are propelling Leuprolide Acetate market. Intramuscular, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Subcutaneous segment is estimated at % CAGR for the next seven-year period.
Leuprorelin was approved for medical use in the United States in 1985. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. In the United Kingdom a monthly dose costs the NHS about 75.24 pounds. In the United States the equivalent dose has a wholesale cost of 1,011.93 USD.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Mode of Administration, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Leuprolide Acetate, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Leuprolide Acetate market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Leuprolide Acetate market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Leuprolide Acetate sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Leuprolide Acetate covered in this report include Tolmar Pharmaceuticals, Varian Pharmed, Avenit, Takeda Pharmaceutical, Sun Pharmaceutical Industries, Livzon Pharmaceutical, Beijing Biote Pharmaceutical, Soho-YImIng and AbbVie, etc.
The global Leuprolide Acetate market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Tolmar Pharmaceuticals
Varian Pharmed
Avenit
Takeda Pharmaceutical
Sun Pharmaceutical Industries
Livzon Pharmaceutical
Beijing Biote Pharmaceutical
Soho-YImIng
AbbVie
Sanofi
Astellas Pharma
Abbott
Merck
Pfizer
Global Leuprolide Acetate market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Leuprolide Acetate market, Segment by Mode of Administration:
Intramuscular
Subcutaneous
Global Leuprolide Acetate market, by Application
Prostate Cancer
Precocious
Uterine Fibroid
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Mode of Administration, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Leuprolide Acetate manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Leuprolide Acetate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Leuprolide Acetate Market Overview
1.1 Leuprolide Acetate Product Overview
1.2 Leuprolide Acetate Market Segment by Mode of Administration
1.2.1 Intramuscular
1.2.2 Subcutaneous
1.3 Global Leuprolide Acetate Market Size by Mode of Administration
1.3.1 Global Leuprolide Acetate Market Size Overview by Mode of Administration (2018-2029)
1.3.2 Global Leuprolide Acetate Historic Market Size Review by Mode of Administration (2018-2023)
1.3.3 Global Leuprolide Acetate Forecasted Market Size by Mode of Administration (2024-2029)
1.4 Key Regions Market Size Segment by Mode of Administration
1.4.1 North America Leuprolide Acetate Sales Breakdown by Mode of Administration (2018-2023)
1.4.2 Europe Leuprolide Acetate Sales Breakdown by Mode of Administration (2018-2023)
1.4.3 Asia-Pacific Leuprolide Acetate Sales Breakdown by Mode of Administration (2018-2023)
1.4.4 Latin America Leuprolide Acetate Sales Breakdown by Mode of Administration (2018-2023)
1.4.5 Middle East and Africa Leuprolide Acetate Sales Breakdown by Mode of Administration (2018-2023)
2 Global Leuprolide Acetate Market Competition by Company
2.1 Global Top Players by Leuprolide Acetate Sales (2018-2023)
2.2 Global Top Players by Leuprolide Acetate Revenue (2018-2023)
2.3 Global Top Players by Leuprolide Acetate Price (2018-2023)
2.4 Global Top Manufacturers Leuprolide Acetate Manufacturing Base Distribution, Sales Area, Product Type
2.5 Leuprolide Acetate Market Competitive Situation and Trends
2.5.1 Leuprolide Acetate Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Leuprolide Acetate Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Leuprolide Acetate as of 2022)
2.7 Date of Key Manufacturers Enter into Leuprolide Acetate Market
2.8 Key Manufacturers Leuprolide Acetate Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Leuprolide Acetate Status and Outlook by Region
3.1 Global Leuprolide Acetate Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Leuprolide Acetate Historic Market Size by Region
3.2.1 Global Leuprolide Acetate Sales in Volume by Region (2018-2023)
3.2.2 Global Leuprolide Acetate Sales in Value by Region (2018-2023)
3.2.3 Global Leuprolide Acetate Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Leuprolide Acetate Forecasted Market Size by Region
3.3.1 Global Leuprolide Acetate Sales in Volume by Region (2024-2029)
3.3.2 Global Leuprolide Acetate Sales in Value by Region (2024-2029)
3.3.3 Global Leuprolide Acetate Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Leuprolide Acetate by Application
4.1 Leuprolide Acetate Market Segment by Application
4.1.1 Prostate Cancer
4.1.2 Precocious
4.1.3 Uterine Fibroid
4.1.4 Others
4.2 Global Leuprolide Acetate Market Size by Application
4.2.1 Global Leuprolide Acetate Market Size Overview by Application (2018-2029)
4.2.2 Global Leuprolide Acetate Historic Market Size Review by Application (2018-2023)
4.2.3 Global Leuprolide Acetate Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Leuprolide Acetate Sales Breakdown by Application (2018-2023)
4.3.2 Europe Leuprolide Acetate Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Leuprolide Acetate Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Leuprolide Acetate Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Leuprolide Acetate Sales Breakdown by Application (2018-2023)
5 North America Leuprolide Acetate by Country
5.1 North America Leuprolide Acetate Historic Market Size by Country
5.1.1 North America Leuprolide Acetate Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Leuprolide Acetate Sales in Volume by Country (2018-2023)
5.1.3 North America Leuprolide Acetate Sales in Value by Country (2018-2023)
5.2 North America Leuprolide Acetate Forecasted Market Size by Country
5.2.1 North America Leuprolide Acetate Sales in Volume by Country (2024-2029)
5.2.2 North America Leuprolide Acetate Sales in Value by Country (2024-2029)
6 Europe Leuprolide Acetate by Country
6.1 Europe Leuprolide Acetate Historic Market Size by Country
6.1.1 Europe Leuprolide Acetate Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Leuprolide Acetate Sales in Volume by Country (2018-2023)
6.1.3 Europe Leuprolide Acetate Sales in Value by Country (2018-2023)
6.2 Europe Leuprolide Acetate Forecasted Market Size by Country
6.2.1 Europe Leuprolide Acetate Sales in Volume by Country (2024-2029)
6.2.2 Europe Leuprolide Acetate Sales in Value by Country (2024-2029)
7 Asia-Pacific Leuprolide Acetate by Region
7.1 Asia-Pacific Leuprolide Acetate Historic Market Size by Region
7.1.1 Asia-Pacific Leuprolide Acetate Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Leuprolide Acetate Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Leuprolide Acetate Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Leuprolide Acetate Forecasted Market Size by Region
7.2.1 Asia-Pacific Leuprolide Acetate Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Leuprolide Acetate Sales in Value by Region (2024-2029)
8 Latin America Leuprolide Acetate by Country
8.1 Latin America Leuprolide Acetate Historic Market Size by Country
8.1.1 Latin America Leuprolide Acetate Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Leuprolide Acetate Sales in Volume by Country (2018-2023)
8.1.3 Latin America Leuprolide Acetate Sales in Value by Country (2018-2023)
8.2 Latin America Leuprolide Acetate Forecasted Market Size by Country
8.2.1 Latin America Leuprolide Acetate Sales in Volume by Country (2024-2029)
8.2.2 Latin America Leuprolide Acetate Sales in Value by Country (2024-2029)
9 Middle East and Africa Leuprolide Acetate by Country
9.1 Middle East and Africa Leuprolide Acetate Historic Market Size by Country
9.1.1 Middle East and Africa Leuprolide Acetate Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Leuprolide Acetate Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Leuprolide Acetate Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Leuprolide Acetate Forecasted Market Size by Country
9.2.1 Middle East and Africa Leuprolide Acetate Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Leuprolide Acetate Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Tolmar Pharmaceuticals
10.1.1 Tolmar Pharmaceuticals Company Information
10.1.2 Tolmar Pharmaceuticals Introduction and Business Overview
10.1.3 Tolmar Pharmaceuticals Leuprolide Acetate Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Tolmar Pharmaceuticals Leuprolide Acetate Products Offered
10.1.5 Tolmar Pharmaceuticals Recent Development
10.2 Varian Pharmed
10.2.1 Varian Pharmed Company Information
10.2.2 Varian Pharmed Introduction and Business Overview
10.2.3 Varian Pharmed Leuprolide Acetate Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Varian Pharmed Leuprolide Acetate Products Offered
10.2.5 Varian Pharmed Recent Development
10.3 Avenit
10.3.1 Avenit Company Information
10.3.2 Avenit Introduction and Business Overview
10.3.3 Avenit Leuprolide Acetate Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Avenit Leuprolide Acetate Products Offered
10.3.5 Avenit Recent Development
10.4 Takeda Pharmaceutical
10.4.1 Takeda Pharmaceutical Company Information
10.4.2 Takeda Pharmaceutical Introduction and Business Overview
10.4.3 Takeda Pharmaceutical Leuprolide Acetate Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Takeda Pharmaceutical Leuprolide Acetate Products Offered
10.4.5 Takeda Pharmaceutical Recent Development
10.5 Sun Pharmaceutical Industries
10.5.1 Sun Pharmaceutical Industries Company Information
10.5.2 Sun Pharmaceutical Industries Introduction and Business Overview
10.5.3 Sun Pharmaceutical Industries Leuprolide Acetate Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Sun Pharmaceutical Industries Leuprolide Acetate Products Offered
10.5.5 Sun Pharmaceutical Industries Recent Development
10.6 Livzon Pharmaceutical
10.6.1 Livzon Pharmaceutical Company Information
10.6.2 Livzon Pharmaceutical Introduction and Business Overview
10.6.3 Livzon Pharmaceutical Leuprolide Acetate Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Livzon Pharmaceutical Leuprolide Acetate Products Offered
10.6.5 Livzon Pharmaceutical Recent Development
10.7 Beijing Biote Pharmaceutical
10.7.1 Beijing Biote Pharmaceutical Company Information
10.7.2 Beijing Biote Pharmaceutical Introduction and Business Overview
10.7.3 Beijing Biote Pharmaceutical Leuprolide Acetate Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Beijing Biote Pharmaceutical Leuprolide Acetate Products Offered
10.7.5 Beijing Biote Pharmaceutical Recent Development
10.8 Soho-YImIng
10.8.1 Soho-YImIng Company Information
10.8.2 Soho-YImIng Introduction and Business Overview
10.8.3 Soho-YImIng Leuprolide Acetate Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Soho-YImIng Leuprolide Acetate Products Offered
10.8.5 Soho-YImIng Recent Development
10.9 AbbVie
10.9.1 AbbVie Company Information
10.9.2 AbbVie Introduction and Business Overview
10.9.3 AbbVie Leuprolide Acetate Sales, Revenue and Gross Margin (2018-2023)
10.9.4 AbbVie Leuprolide Acetate Products Offered
10.9.5 AbbVie Recent Development
10.10 Sanofi
10.10.1 Sanofi Company Information
10.10.2 Sanofi Introduction and Business Overview
10.10.3 Sanofi Leuprolide Acetate Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Sanofi Leuprolide Acetate Products Offered
10.10.5 Sanofi Recent Development
10.11 Astellas Pharma
10.11.1 Astellas Pharma Company Information
10.11.2 Astellas Pharma Introduction and Business Overview
10.11.3 Astellas Pharma Leuprolide Acetate Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Astellas Pharma Leuprolide Acetate Products Offered
10.11.5 Astellas Pharma Recent Development
10.12 Abbott
10.12.1 Abbott Company Information
10.12.2 Abbott Introduction and Business Overview
10.12.3 Abbott Leuprolide Acetate Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Abbott Leuprolide Acetate Products Offered
10.12.5 Abbott Recent Development
10.13 Merck
10.13.1 Merck Company Information
10.13.2 Merck Introduction and Business Overview
10.13.3 Merck Leuprolide Acetate Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Merck Leuprolide Acetate Products Offered
10.13.5 Merck Recent Development
10.14 Pfizer
10.14.1 Pfizer Company Information
10.14.2 Pfizer Introduction and Business Overview
10.14.3 Pfizer Leuprolide Acetate Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Pfizer Leuprolide Acetate Products Offered
10.14.5 Pfizer Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Leuprolide Acetate Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Leuprolide Acetate Industrial Chain Analysis
11.4 Leuprolide Acetate Market Dynamics
11.4.1 Leuprolide Acetate Industry Trends
11.4.2 Leuprolide Acetate Market Drivers
11.4.3 Leuprolide Acetate Market Challenges
11.4.4 Leuprolide Acetate Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Leuprolide Acetate Distributors
12.3 Leuprolide Acetate Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
